Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy

Affiliations

¹ Ministry of Health, Madrid, Spain.
² University Hospital Ramón y Cajal and HIV Network of Excellence, Madrid, Spain.
³ Institute of Health Carlos III, Ministry of Health, and HIV Network of Excellence, Madrid, Spain.
⁴ University Hospital Clinic, Barcelona, Spain, and HIV Network of Excellence, Madrid, Spain.
⁵ University Hospital La Paz, IdiPAZ, and HIV Network of Excellence, Madrid, Spain.
⁶ Institute of Health Carlos III and HIV Network of Excellence, Madrid, Spain.
⁷ Harvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts.

Free article

Comment

Julia Del Amo et al. Ann Intern Med. 2021 Apr.

Free article

. 2021 Apr;174(4):581-582.

doi: 10.7326/L20-1399.

¹ Ministry of Health, Madrid, Spain.
² University Hospital Ramón y Cajal and HIV Network of Excellence, Madrid, Spain.
³ Institute of Health Carlos III, Ministry of Health, and HIV Network of Excellence, Madrid, Spain.
⁴ University Hospital Clinic, Barcelona, Spain, and HIV Network of Excellence, Madrid, Spain.
⁵ University Hospital La Paz, IdiPAZ, and HIV Network of Excellence, Madrid, Spain.
⁶ Institute of Health Carlos III and HIV Network of Excellence, Madrid, Spain.
⁷ Harvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts.

No abstract available

Comment on

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.
Titanji B, Hernandez-Romieu AC, Adelman MW. Titanji B, et al. Ann Intern Med. 2021 Apr;174(4):580-581. doi: 10.7326/L20-1398. Ann Intern Med. 2021. PMID: 33872542 No abstract available.